Genesee Capital Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$942K Sell
31,607
-3,769
-11% -$116K 0.3% 71
2026
Q2
$1.23M Sell
35,376
-3,774
-10% -$101K 0.39% 54
2026
Q1
$813K Sell
39,150
-188
-0.5% -$4.44K 0.34% 65
2025
Q4
$1.28M Buy
39,338
+2,264
+6% +$97K 0.51% 46
2025
Q3
$2.1M Sell
37,074
-625
-2% -$32K 0.91% 24
2025
Q2
$1.88M Buy
37,699
+3,013
+9% +$136K 0.84% 28
2025
Q1
$1.02M Sell
34,686
-2,063
-6% -$76.6K 0.51% 43
2024
Q4
$889K Buy
+36,749
New +$910K 0.41% 56

Other funds holding HIMS

Genesee Capital Advisors's HIMS Position: Q3 2026 in Review

Genesee Capital Advisors reduced its Hims & Hers Health (HIMS) stake by 11% in Q3 2026, selling an estimated $116K and leaving 31,607 shares worth $942K. The position accounts for 0.3% of the portfolio, ranked #71.

Genesee Capital Advisors first reported a position in HIMS in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.1M in Q3 2025. 475 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Genesee Capital Advisors held 31,607 shares of Hims & Hers Health worth $942K as of Q3 2026.
  • Genesee Capital Advisors sold 3,769 Hims & Hers Health shares in Q3 2026, an estimated $116K.
  • Hims & Hers Health made up 0.3% of Genesee Capital Advisors's portfolio in Q3 2026, its #71 holding.
  • Genesee Capital Advisors first reported a position in Hims & Hers Health in Q4 2024 and has held it in 8 quarters since.
  • Genesee Capital Advisors's Hims & Hers Health position peaked at $2.1M in Q3 2025.
  • 475 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Genesee Capital Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.